Allen L V, Stiles M L
University of Oklahoma Health Sciences Center, College of Pharmacy, Oklahoma City 73190.
J Anal Toxicol. 1988 Jan-Feb;12(1):45-7. doi: 10.1093/jat/12.1.45.
An investigation to determine the specificity of the EMIT d.a.u. assays was conducted. Samples of drug-free urine from healthy volunteers were spiked individually with one of 162 drugs to a concentration of 1000 mg/L. These samples were analyzed with the EMIT d.a.u. assays for phencyclidine and cannabinoids. Although some of the assays yielded positive results at this concentration, negative results were obtained in all samples diluted to 100, 10, and 1 mg/L.
开展了一项调查以确定酶放大免疫测定技术（EMIT d.a.u.）检测的特异性。从健康志愿者采集的无药物尿液样本分别添加162种药物中的一种，使其浓度达到1000毫克/升。这些样本采用EMIT d.a.u.检测法检测苯环己哌啶和大麻素。尽管某些检测法在该浓度下产生了阳性结果，但在稀释至100、10和1毫克/升的所有样本中均获得阴性结果。
